Institutional investors purchased a net $14.9 million shares of SGYP during the quarter ended March 2016 and now own 45.47% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PAULSON & CO., INC. Bought 16.7 Million shares of Synergy Pharmaceuticals I...